MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

AngioDynamics Inc

Chiusa

SettoreSettore sanitario

8.68 -0.12

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

8.43

Massimo

8.79

Metriche Chiave

By Trading Economics

Entrata

6.3M

-4.4M

Vendite

-841K

72M

EPS

-0.03

Margine di Profitto

-6.12

Dipendenti

748

EBITDA

-2.1M

-329K

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+117.39% upside

Dividendi

By Dow Jones

Utili prossimi

2 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

6.6M

391M

Apertura precedente

8.8

Chiusura precedente

8.68

Notizie sul Sentiment di mercato

By Acuity

72%

28%

340 / 376 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

AngioDynamics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

9 dic 2024, 15:23 UTC

I principali Market Mover

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9 dic 2024, 15:20 UTC

I principali Market Mover

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

Confronto tra pari

Modifica del prezzo

AngioDynamics Inc Previsione

Obiettivo di Prezzo

By TipRanks

117.39% in crescita

Previsioni per 12 mesi

Media 19 USD  117.39%

Alto 24 USD

Basso 16 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per AngioDynamics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

9 / 9.3Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Very Strong Bearish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

340 / 376 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.